News Image

IO Biotech Announces Participation in Upcoming Investor Conferences

Provided By GlobeNewswire

Last update: Aug 26, 2024

NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform, today announced that members of its senior management team will provide a corporate update and participate in one-on-one meetings at the following upcoming investor conferences:

Read more at globenewswire.com

IO BIOTECH INC

NASDAQ:IOBT (6/12/2025, 6:32:32 PM)

1.5

0 (0%)



Find more stocks in the Stock Screener

Follow ChartMill for more